Financing, Equity Capital Markets

Milestone Pharmaceuticals, Inc.

02/24
|
$30.0 Million
milestone
Piper Sandler served as sole bookrunner for Milestone Pharmaceuticals, Inc. on a confidentially marketed follow-on offering
Sub-Type
Confidentially Marketed Follow-On Offering
Sub-Sector
Biopharma